US Stock MarketDetailed Quotes

RVNC Revance Therapeutics(Delisted)

Watchlist
  • 3.650
  • 0.0000.00%
Close Feb 5 16:00 ET
381.02MMarket Cap-1.90P/E (TTM)

Revance Therapeutics(Delisted) Key Stats

Revance Therapeutics(Delisted) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q359.879M / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--
Nov 8, 20232023/Q356.776M / 58.742M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q359.879M / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--
Nov 8, 20232023/Q356.776M / 58.742M--

Unlock Free Earnings Estimates

Revance Therapeutics(Delisted) Earnings Reports

Read more

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now